Q3989231 (Q3989231): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) Tag: Replaced |
(Changed an Item: importing one item from Netherlands) |
||||||||||||||
| Property / instance of | |||||||||||||||
| Property / instance of: Kohesio project / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / financed by | |||||||||||||||
| Property / financed by: European Union / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / country | |||||||||||||||
| Property / country: Kingdom of the Netherlands / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
1 July 2017
| |||||||||||||||
| Property / start time: 1 July 2017 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
30 June 2020
| |||||||||||||||
| Property / start time: 30 June 2020 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
Lead Pharma Holding | |||||||||||||||
| Property / beneficiary name (string): Lead Pharma Holding / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q3986142 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
306,823.43 Euro
| |||||||||||||||
| Property / EU contribution: 306,823.43 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
1,998,722.03 Euro
| |||||||||||||||
| Property / budget: 1,998,722.03 Euro / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
15.351 percent
| |||||||||||||||
| Property / co-financing rate: 15.351 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / fund | |||||||||||||||
| Property / fund: European Regional Development Fund / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / postal code | |||||||||||||||
6534 AT | |||||||||||||||
| Property / postal code: 6534 AT / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / programme | |||||||||||||||
| Property / programme: East Netherlands - ERDF / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Research and innovation processes in SMEs (including voucher schemes, process, design, service and social innovation) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 15:48, 13 December 2021
Project Q3989231 in Netherlands
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3989231 in Netherlands |
Statements
306,823.43 Euro
0 references
1,998,722.03 Euro
0 references
15.351 percent
0 references
1 July 2017
0 references
30 June 2020
0 references
Lead Pharma Holding
0 references
6534 AT
0 references
Identifiers
OP-2014-2023-Oost-PROJ-00697
0 references